Bacterin International Holdings, Inc. to Present at the OneMed Forum Conference
Bacterin International Holdings, Inc.(NYSE Amex: BONE), a leader in the
development of revolutionary bone graft material and antimicrobial
coatings for medical applications, today announced it will be presenting
at the 6th Annual OneMed Forum Conference held at the Sir Francis Drake
Hotel in San Francisco, California. John Gandolfo, Bacterin's Chief
Financial Officer, will provide a company presentation on Wednesday,
January 9, 2013 at 10:30 AM Pacific Time.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops,
manufactures and markets biologics products to domestic and
international markets. Bacterin's proprietary methods optimize the
growth factors in human allografts to create the ideal stem cell
scaffold to promote bone, subchondral repair and dermal growth. These
products are used in a variety of applications including enhancing
fusion in spine surgery, relief of back pain, promotion of bone growth
in foot and ankle surgery, promotion of cranial healing following
neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses
bioactive coatings for various medical device applications. Bacterin's
strategic coating initiatives include antimicrobial coatings designed to
inhibit biofilm formation and microbial contamination. For further
information, please visit www.bacterin.com.
